Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GRCL - Gracell wins Medical Products Manufacturing Certificate for site in China

GRCL - Gracell wins Medical Products Manufacturing Certificate for site in China

Gracell Biotechnologies Inc.
Gracell Biotechnologies (GRCL) has been granted the Medical Products Manufacturing Certificate ((MPMC)) from the Jiangsu Medical Products Administration in China for its CAR-T cell therapy products.The certification was granted on January 4, 2021, and indicates that Gracell's site in Suzhou Industrial Park ((SIP)) has fully met the compliance requirements for Good Manufacturing Practice ((GMP)) in relation to the production of CAR-T cell therapy for cancer treatment.The MPMC certification for Gracell follows an on-site inspection conducted by JSMPA inspectors at its Suzhou site in November last year.

For further details see:

Gracell wins Medical Products Manufacturing Certificate for site in China
Stock Information
Company Name: Gracell Biotechnologies Inc.
Stock Symbol: GRCL
Market: NASDAQ
Website: gracellbio.com
Menu
GRCL GRCL Quote GRCL Short GRCL News GRCL Articles GRCL Message Board
Get GRCL Alerts

News, Short Squeeze, Breakout and More Instantly...